Page 406 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 406

392     SECTION V  Drugs That Act in the Central Nervous System


                   Meprobamate and the benzodiazepines have frequently been   depressants, including ethanol. In fact, most serious cases of drug
                 used as central muscle relaxants, though evidence for general   overdosage,  intentional  or  accidental,  do  involve  polypharmacy;
                 efficacy without accompanying sedation is lacking. A possible   and when combinations of agents are taken, the practical safety of
                 exception is diazepam, which has useful relaxant effects in skeletal   benzodiazepines may be less than the foregoing would imply.
                 muscle spasticity of central origin (see Chapter 27).  The lethal dose of any sedative-hypnotic varies with the patient
                   Psychiatric uses of benzodiazepines other than treatment of   and the circumstances (see Chapter 58). If discovery of the inges-
                 anxiety states include the initial management of mania and the   tion is made early and a conservative treatment regimen is started,
                 control of drug-induced hyperexcitability states (eg, phencyclidine   the outcome is rarely fatal, even following very high doses. On the
                 intoxication). Sedative-hypnotics are also used occasionally as   other hand, for most sedative-hypnotics—with the exception of
                 diagnostic aids in neurology and psychiatry.        benzodiazepines and possibly the newer hypnotic drugs that have
                                                                     a similar mechanism of action—a dose as low as 10 times the hyp-
                 CLINICAL TOXICOLOGY OF                              notic dose may be fatal if the patient is not discovered or does not
                 SEDATIVE-HYPNOTICS                                  seek help in time. With severe toxicity, the respiratory depression
                                                                     from central actions of the drug may be complicated by aspiration
                                                                     of gastric contents in the unattended patient—an even more likely
                 Direct Toxic Actions                                occurrence if ethanol is present. Cardiovascular depression further
                 Many of the common adverse effects of sedative-hypnotics result   complicates successful resuscitation. In such patients, treatment
                 from dose-related depression of the CNS. Relatively low doses may   consists of ensuring a patent airway, with mechanical ventilation
                 lead to drowsiness, impaired judgment, and diminished motor skills,   if needed, and maintenance of plasma volume, renal output, and
                 sometimes with a significant impact on driving ability, job perfor-  cardiac function. Use of a positive inotropic drug such as dopa-
                 mance, and personal relationships. Sleep driving and other somnam-  mine, which preserves renal blood flow, is sometimes indicated.
                 bulistic behavior with no memory of the event have occurred with the   Hemodialysis or hemoperfusion may be used to hasten elimina-
                 sedative-hypnotic drugs used in sleep disorders, prompting the FDA   tion of some of these drugs (see Table 58–2).
                 in 2007 to issue warnings of this potential hazard. Benzodiazepines   Flumazenil reverses the sedative actions of benzodiazepines, and
                 may cause a significant dose-related anterograde amnesia; they can   those of eszopiclone, zaleplon, and zolpidem, although experience
                 significantly impair ability to learn new information, particularly   with its use in overdose of the newer hypnotics is limited. How-
                 that involving effortful cognitive processes, while leaving the retrieval   ever, its duration of action is short, its antagonism of respiratory
                 of previously learned information intact. This effect is utilized for   depression is unpredictable, and there is a risk of precipitation of
                 uncomfortable clinical procedures, eg, endoscopy, because the patient   withdrawal symptoms in long-term users of benzodiazepines. Con-
                 is able to cooperate during the procedure but amnesic regarding it   sequently, the use of flumazenil in benzodiazepine overdose remains
                 afterward. The criminal use of benzodiazepines in cases of “date rape”   controversial and  must be accompanied by adequate monitoring
                 is based on their dose-dependent amnestic effects. Hangover effects   and support of respiratory function. The extensive clinical use of
                 are not uncommon following use of hypnotic drugs with long elimi-  triazolam has led to reports of serious CNS effects including behav-
                 nation half-lives. Because elderly patients are more sensitive to the   ioral disinhibition, delirium, aggression, and violence. However,
                 effects of sedative-hypnotics, doses approximately half of those used   behavioral  disinhibition may  occur  with any sedative-hypnotic
                 in younger adults are safer and usually as effective. The most common   drug, and it does not appear to be more prevalent with triazolam
                 reversible cause of confusional states in the elderly is overuse of sedative-  than with other benzodiazepines. Disinhibitory reactions during
                 hypnotics. At higher doses, toxicity may present as lethargy or a state   benzodiazepine treatment are more clearly associated with the use
                 of exhaustion or, alternatively, as gross symptoms equivalent to those   of very high doses and the pretreatment level of patient hostility.
                 of ethanol intoxication. The physician should be aware of variability   Adverse effects of the sedative-hypnotics that are not referable
                 among patients in terms of doses causing adverse effects. An increased   to their CNS actions occur infrequently. Hypersensitivity reac-
                 sensitivity to sedative-hypnotics is more common in patients with   tions, including skin rashes, occur only occasionally with most
                 cardiovascular disease, respiratory disease, or hepatic impairment and   drugs of this class. Reports of teratogenicity leading to fetal defor-
                 in older patients. Sedative-hypnotics can exacerbate breathing prob-  mation following use of certain benzodiazepines have resulted
                 lems in patients with chronic pulmonary disease and in those with   in FDA assignment of individual benzodiazepines to either cat-
                 symptomatic sleep apnea.                            egory D or X in terms of pregnancy risk. Most barbiturates are
                   Sedative-hypnotics are the drugs most frequently involved in   FDA pregnancy category D. Eszopiclone, ramelteon, suvorexant,
                 deliberate overdoses, in part because of their general availability as   zaleplon, and zolpidem are category C, while buspirone is a cat-
                 very commonly prescribed pharmacologic agents. The benzodiaz-  egory B drug in terms of use in pregnancy. Because barbiturates
                 epines are considered to be safer drugs in this respect, since they   enhance porphyrin synthesis, they are absolutely contraindicated in
                 have flatter dose-response curves. Epidemiologic studies on the inci-  patients with a history of acute intermittent porphyria, variegate
                 dence of drug-related deaths support this general assumption—eg,   porphyria, hereditary coproporphyria, or symptomatic porphyria.
                 0.3 deaths per million tablets of diazepam prescribed versus 11.6
                 deaths per million capsules of secobarbital in one study. Alprazolam   Alterations in Drug Response
                 is purportedly more toxic in overdose than other benzodiazepines.
                 Of course, many factors other than the specific sedative-hypnotic   Depending  on  the  dosage  and  the  duration  of  use,  tolerance
                 could influence such data—particularly the presence of other CNS   occurs in varying degrees to many of the pharmacologic effects
   401   402   403   404   405   406   407   408   409   410   411